SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-009382
Filing Date
2023-03-29
Accepted
2023-03-29 07:35:32
Documents
14
Period of Report
2023-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36591
2 ex99-1.htm EX-99.1 66738
3 ex99-1_001.jpg GRAPHIC 3850
  Complete submission text file 0001493152-23-009382.txt   293784

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20230329.xsd EX-101.SCH 3257
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20230329_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20230329_pre.xml EX-101.PRE 22379
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3607
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 23771778
SIC: 2834 Pharmaceutical Preparations